Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OrthoStim is a Canadian medical device company focused on developing non-invasive treatments for adolescent idiopathic scoliosis (AIS). The company's lead product, O-Stim, utilizes functional electrical stimulation (FES) to target and strengthen paraspinal muscles, aiming to halt or reverse spinal curvature without the need for rigid bracing or invasive surgery. By providing a more comfortable and less stigmatizing alternative to traditional treatments, OrthoStim seeks to improve compliance and clinical outcomes for young patients. The technology is based on clinical research demonstrating the efficacy of surface electrical stimulation in stabilizing spinal deformities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ortho Stim.